Skip to main content

Table 4 Adjusted cox proportional hazard model for blip participants compared to controls

From: Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study

Characteristics

Blip group

N (%) or mean (SD)

Control group

N (%) or mean (SD)

Multivariate hazard ratio (95 % CI)

P value

Number, n

99

673

  

Mean age at ART (years)

34.4 (14.9)

32.9 (13.4)

1 (0.98,1.02)

0.9737

Race

 Caucasian

38 (38.4)

267 (39.7)

Ref

 

 African-American

49 (49.5)

278 (41.3)

1.14 (0.73,1.78)

0.5773

 Other

12 (12.1)

128 (19.0)

0.68 (0.35,1.35)

0.2727

Viral load at ART initiation (log10 copies/mL)

4.8 (0.9)

4.5 (1.0)

1.42 (1.08,1.88)

0.0123

CD4 cell count at ART initiation (cells/µL)

 0–350

64 (68.1)

305 (49.7)

Ref

 

 350 to <500

22 (23.4)

190 (30.9)

0.64 (0.39,1.05)

0.0793

 ≥500

8 (8.5)

119 (19.4)

0.45 (0.22, 0.95)

0.0365

Self-reported antiretroviral drug adherence (%)

 ≥85

96 (98.0)

637 (96.2)

Ref

 

 <85

2 (2.0)

25 (3.8)

0.5 (0.12, 2.04)

0.3335

  1. Data expressed as N (%) or mean (SD)
  2. ART antiretroviral therapy